NLM Logo

cemiplimab MeSH Supplementary Concept Data 2025


MeSH Supplementary
cemiplimab
Unique ID
C000627974
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000627974
Entry Term(s)
REGN2810
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
6QVL057INT
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
104
Note
human monoclonal antibody against programmed cell death 1 protein (PD-1) for the treatment of metastatic or unresectable cutaneous squamous cell carcinoma (CSCC)
Source
N Engl J Med. 2018 Jul 26;379(4):341-351.
Date of Entry
2018/08/16
Revision Date
2019/12/01
cemiplimab Preferred
REGN2810 Narrower
page delivered in 0.007s